載入...
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
BACKGROUND: Accurately monitoring and collecting drug adherence data can allow for better understanding and interpretation of the outcomes of clinical trials. Most clinical trials use a combination of pill counts and self-reported data to measure drug adherence, despite the drawbacks of relying on t...
Na minha lista:
發表在: | JMIR Mhealth Uhealth |
---|---|
Main Authors: | , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
JMIR Publications
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340925/ https://ncbi.nlm.nih.gov/pubmed/28223265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/mhealth.7030 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|